Southern Crop

Southern Crop

Industry Seeks Glyphosate Decision After EPA Finds Cancer Risk Unlikely

A pesticide industry source is arguing that EPA’s finding that glyphosate is unlikely to cause human cancers should spur the agency to expedite its long-delayed registration review of the substance rather than continue with a planned Scientific Advisory Panel (SAP) review on whether the world’s most commonly-used herbicide causes cancer.

 

Read more

Related Articles

Update – Enlist Duo, an Herbicide product containing 2,4-D and Glyphosate – Environmental groups have sued the EPA for granting a conditional registration of Enlist Duo, alleging that “… EPA violated its duties under the Pesticide Act in issuing the conditional registration. Petitioners further request [the] Court to find that[…]

Read More »

‘The Impact of Asynchronous Approvals for Biotech Crops on Agricultural Sustainability, Trade, and Innovation’ is the title of an Research Paper released by the Council for Agricultural Science and Technology (CAST) which “… outlines the main economic effects of the observed asynchrony in approvals for biotech-improved crops from regulatory systems[…]

Read More »

Leave a Reply

Your email address will not be published. Required fields are marked *